When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMCR - Engimmune Therapeutics gets Dr. Lars Nieba as CEO
Immunocore Holdings plc
2023-04-19 04:36:59 ET
Swiss biotech company developing novel T-cell receptor-based therapeutics, Engimmune Therapeutics AG ( NASDAQ: IMCR ) appoints Dr. Lars Nieba as CEO.
Dr. Søren Mouritsen, co-founder and previous CEO, steps down in a planned transition.
Dr. Lars Nieba brings more than 25 years of experience in biopharmaceutical leadership and has held previous positions in big pharma and VC firms including Roche, Bayer and Pureos Bioventures.